View Older Stories
-
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
-
AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE
-
Citi Starts Amgen (AMGN) at Neutral
-
Ideaya Biosciences (IDYA) Mentioned Positively at Citi, 'developing into an attractive takeout candidate'
-
AMGEN TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE
-
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc
-
3 Rumors Pushing Around Stocks Today
-
AMGEN ANNOUNCES WEBCAST OF 2022 CITI GLOBAL HEALTHCARE CONFERENCE
-
Amgen to Present at the 16th Annual Citi BioPharma Conference
-
Pre-Open Stock Movers 10/08: (EV) (ATEC) (IBM) Higher; (CYTK) (DPZ) (AMGN) Lower (more...)
-
Amgen (AMGN) Added to Positive Catalyst Watch List at Citi
-
Amgen To Present At The 15th Annual Citi BioPharma Conference
-
Pre-Open Movers 08/25: (OVID) (GPS) (CRM) Higher; (PLCE) (POR) (PANW) Lower (more...)
-
COVID-19 Presents a Headwind for Amgen (AMGN) and Coherus BioSciences (CHRS) - Citi
-
Amgen (AMGN) PT Raised to $275 at Citi
-
Bristol-Myers Squibb (BMY) Completes Acquisition of Celgene (CELG)
-
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
-
S&P 500 Q2 Stock Buybacks Fall 20.1% Sequentially, 13.7% YoY
-
S&P 500 buybacks decline significantly in Q2 2019; expenditures still remain higher than the pre-2018 levels
-
Amgen (AMGN) PT Raised to $215 at Citi
-
Citi Upgrades Amgen (AMGN) to Buy
-
Citi Upgrades Amgen (AMGN) to Buy
-
Amgen (AMGN) EVENITY Pricing In-Line; Fair Value Target Raised - Citi
-
S&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly Record at $223 Billion; 2018 Sets Record $806 Billion
-
Amgen (AMGN) PT Lowered to $211 at Citi
-
Pre-Open Stock Movers 01/22: (EBAY) (UAA) (PANW) Higher; (ARNC) (PETS) (SWK) Lower (more...)
-
Amgen (AMGN) PT Moves To $216 At Citi On Neulasta and Sensipar
-
S&P 500 Q3 2018 Buybacks Surpass $200 Billion Mark for the First Time Ever
-
Amgen To Present At The Citi Global Healthcare Conference
-
Amgen (AMGN) PT Raised to $204 at Citi
-
Coming Udencya Approval Likely A Negative Event For Amgen (AMGN) - Citi
-
S&P 500 Q2 2018 Buybacks Increase 58.7% Year-Over-Year to Record $190.6 Billion
-
Amgen (AMGN) PT Raised to $200 at Citi
-
Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO
-
Amgen (AMGN) PT Lowered to $188 at Citi
-
UPDATE: Amgen (AMGN): Raising PT On Tax Rate Changes - Citi
-
Pre-Open Movers 05/22: (NUTR) (RDUS) (EYEG) Higher; (LJPC) (SNCR) (AMGN) Lower (more...)
-
Pre-Open Stock Movers 01/06: (ETRM) (OGXI) (STML) Higher; (RT) (GIII) (REGN) Lower (more...)
-
Amgen To Present At The Citi 2016 Global Healthcare Conference
-
Complete Donald Trump Stock Impact Guide
-
Amgen To Participate In Citi Biotech R&D Conference Call
-
Loeb's Third Point LLC 13F Shows New Stakes Facebook (FB), Activision Blizzard (ATVI), Whiting (WLL) (More...)
-
Amgen Announces Expiration And Final Results Of Senior Notes Exchange Offers
-
Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel
-
Loeb's Third Point LLC 13F Shows New Stakes in Baxalta (BXLT), Lowe's (LOW), Sells eBay (EBAY) ... More
-
Loeb's Third Point LLC Shows New Stake in Google (GOOGL), Lowe's (LOW), Signet (SIG), (more...)
-
Citi Starts Amgen (AMGN) at Neutral
-
Halvorsen's Viking Global Entered Biogen (BIIB), McDonald's (MCD), Sold Amazon (AMZN), Citi (C) in Q4 - 13F
-
Viking Global Investors's 13F Shows New Stakes in Aflac (AFL), Calpine (CPN), Southwestern Energy (SWN), Liquidates Hilton (HLT) ...
-
Loeb's Third Point LLC 13F Shows New Stake Axalta (AXTA), Morgan Stanley (MS), Liquidates T-Mobile (TMUS), Lowers eBay (EBAY) ...

